Exchange: NASDAQ·Updated 07:52 PM EDT
CALC logo

CALC CalciMedica Inc

$1.46
$0.29
(16.57%)
Today
Closed $1.46
$0.3593
(24.61%)
After Hours
Mkt Cap$9.97M
Vol112,192.00

About CALC

CalciMedica, Inc. is a clinical-stage biopharmaceutical company, which engages in developing therapies for life-threatening inflammatory diseases. The firm's product candidate, Auxora, helps in treating acute pancreatitis and asparaginase-associated pancreatitis. The company was founded by Kenneth A. Stauderman and Gonul Velicelebi in 2007 and is headquartered in La Jolla, CA.
79

Extremely Bullish Sentiment

How do you feel about CALC?

MUBSN
$CALC more vol ah than during the session. Should open at this level on monday, from my point of view, this closing was only a oneoff trade before the closin, only 10k shares were needed
6
keokeostwiz
$CALC This shadowy behind the curtain daily AH activity will be an interesting exposure and at the time of motive divulgence will blow the top off of this 1.80 cover…..one can sense a new inertia pattern of AH accumulation that will soon leak into the open sessions providing fuel for share price liftoff…JMO
6
Profitone
$CALC Three potential triggers Announcement of a pharmaceutical partnership This could lead to a significant revaluation if it includes a substantial upfront payment and development funding. Acquisition offer This would be the most powerful catalyst for a sudden surge, depending on the valuation offered. Aggressive buying in the absence of corporate news This could trigger a speculative rally due to limited liquidity, though it would also be more vulnerable to a correction. My verdict I would say there are two distinct narratives for CALC: The corporate story: an experimental drug with potential, a need for funding, and possible collaboration opportunities. The stock market story: low free float, volatility, short positions, and expectations of sharp price movements. These two narratives could converge to drive an extraordinary rally, but they could also evolve independently.
6
MUBSN
$CALC Steps that could follow: 1. Auxora AP partnership: A pharma partner provides an upfront payment and funds clinical development. 2. Stock revaluation: The deal reduces clinical and financial uncertainty, potentially attracting new investors. 3. Warrant exercise: Above $4.0165 and $5, warrant holders could inject up to $33.7M in additional capital (financing for the rest of the trials) Financial independence: CALC can advance the rest of its pipeline without relying entirely on further equity raises. One strategic partnership could kill two birds with one stone: secure funding for Auxora AP while triggering the share-price appreciation needed to unlock up to $33.7M in warrant proceeds, funding the rest of the pipeline.
5
mrtmermer80
$CALC All I am telling you guys, we didn’t have anything yet. This is nit even a volume. There is not even real selling. MM used short shares to stop the momentum and when we have a real volume things will go wild. Very undervalued and underrated stock.
5
pablo4
$CALC this is very impressive volume AH. We traded just over 70K shares all day and in the first hour of AH trading it's done over 30K already.
5
pablo4
$CALC it sure looks like a buyer or perhaps more entices the seller by raising the bid after each momentary setback ....very methodically. I don't have a clue what is actually going on, especially with that last second close at 1.46 where over 66K of the 71K regular trading day volume stayed right there in the upper 1.70s to the lower 1.80s. And whoever sold that handful in the 1.40s at the close could have sold them moments later AH at 1.80 or higher. There seems something afoot to me. JMO
5
pablo4
$CALC somebody with some money can see the value here and is siphoning off the cheap shares. If that's the case, shorts, by shorting, may be simply assisting the buyer and fueling the fire. Yes, a handful of shares took this to 1.46, but some real buying can send this to 5 instantly, as others have already stated here. JMO
5
keokeostwiz
$CALC Management understands the critical need of securing those $4 and $5 warrants…..the time is set to seize the day….CALC faces a crossroads into a questionable future without stable funding,partnership acquisition or just outright sale……Expediant decisions require urgent attention……Carpe Diem
5
keokeostwiz
$CALC The small 3.8M float with 175k short and a majority of shareholders underwater with no interest in selling soon combined with a very thin order book and anticipation building toward a positive news event creates a very volatile equation favorable towards a strong price explosion as shares will be difficult to accumulate in any sizable blocks…..the moment is primed for corporate action and in need of immediate implementation……JMO
5
mrtmermer80
$CALC Little bit of continous buying brought this to this level. I suspect tax harvesting fund is done now. We have to have more buying and volume. We can fo back to $4 level easily.
5
66Caprice327
$CALC Quite an interesting handful of sessions, especially today and into after-hours. The breakout looks technically convincing, with improving volume and buyers continuing to absorb available shares, but I'm still scratching my head over what's driving it. No obvious news or fundamental catalyst that I could find. Could be seller exhaustion, a liquidity-driven move, or perhaps accumulation ahead of something we don't yet know. Encouraging price action, certainly, but I'm curious whether this is the beginning of a sustained reversal or simply a temporary imbalance in supply and demand. Time will tell. I’m here for it. GL✊🏻
5
MUBSN
$CALC it seems that trading activity is similar than yesterday... at least what I see pre market... From my point of view is the same buyer with the same strategy
4
sh64
$CALC wtf r we heading to another split ? This management is crooks shit is keep going down offering after offering and no positive news only collecting money and robbing share holders. Fucking piss off 
1
3
mrtmermer80
$CALC I added around 30K shares today, lowered my average significantly. Lets see if that was a good decision or bad one.
5
66Caprice327
$CALC Like to see another 50k-100k shares traded with a decisive break above 1.23. Interesting. GL
5
66Caprice327
$CALC Interesting change in character over the last 24 hours. Repeated AH prints around $1.80 despite the stock trading near $1.65, followed today by an unusually hollow book with a 1.64–1.80 spread, concentrated bid support around $1.60 and relatively little displayed supply until $1.86–$1.90. Volume remains extremely thin, so this isn’t evidence of accumulation or a reversal…but it’s noticeably different from the persistent selling pressure we’ve been watching for the past month. Worth watching whether actual volume begins following the change in microstructure. As always…I know nothing. GL
4
Super_Marioo
$CALC - this trend looks promising. maybe hedge funds reversed their algorithms. fingers crossed it continues. good luck guys. it’s not easy making money in this business. most of the tickers I monitor are down long term and only have spikes every now and then so this market is only good for trading and not investing.
3
N3mesis
$CALC no idea what happened. Just come back and had a stop loss at $1.6 and it didn't trigger. This really closed at $1.46? Not complaining as price seems back up, but yeah. ?
2
Profitone
$CALC CalciMedica may be at a pivotal stage for AUXORA. The combination of a promising scientific foundation, new funding avenues, and the prospect of a future strategic collaboration creates a scenario with the potential for value appreciation. An "at-the-market" (ATM) program of up to $25 million provides financial flexibility, while a potential pharmaceutical partner could bolster funding, accelerate clinical development, and reduce uncertainty regarding the project's future.
2

Advertisement|Remove ads.